InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
19,016.40
(
0.31%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
84.92
(
-0.42%
)
Bitcoin
60,831.02
(
0.94%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

cablejohn

Send PM Follow Ignore
Followers 34
Posts 3178
Boards Moderated 0
Alias Born 10/20/2012

cablejohn

Re: itwillgetbetter post# 10872

Monday, 11/18/2013 3:09:16 PM

Monday, November 18, 2013 3:09:16 PM

Post# of 20775
CONJUMAB-1 what can you say, Bio-Pharma has to be interested.
Dr. Chain's presentation, which begins at 10:00 am local time on March 12th, features the company's CONJUMAB platform technology, including its lead compound, CONJUMAB-A, an antibody drug conjugate being developed for age-related macular degeneration (AMD) as well as the company's tau antibody technology. Dr. Chain will also be attending the 11th Annual Conference on Alzheimer's disease and Parkinson's disease from March 6-10 in Florence, Italy.

LINK
http://seekingalpha.com/news-article/5778651-intellect-neurosciences-to-present-at-bio-europe-spring-conference-in-barcelona
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up